DF | F | p | Post hoc t test p values | |||
---|---|---|---|---|---|---|
PD vs PSP | PD vs CBD | PSP vs CBD | ||||
ACE-R | 2 | 18.4 | <0.0001* | <0.0001* | 0.08 | ns |
MMSE | 2 | 18.6 | <0.0001* | 0.002* | ns | ns |
Attention/concentration | 2 | 28.6 | <0.0001* | 0.01* | ns | ns |
Memory | 2 | 3.4 | ns | |||
Fluency | 2 | 51.7 | <0.0001* | <0.0001* | 0.07 | 0.02* |
Language | 2 | 13.9 | <0.0001* | 0.01* | ns | ns |
Visuospatial | 2 | 0.5 | <0.0001* | 0.005* | 0.02* | ns |
Combined fluency score | 2 | 30.64 | <0.0001* | <0.0001* | ns | 0.04* |
Post hoc t tests are shown wherever analysis of variance showed a significant group difference.
*Significant Bonferroni corrected p values <0.05. ns=not significant, p>0.1.
ACE-R, Addenbrooke's Cognitive Examination Revised; CBD, corticobasal degeneration; MMSE, Mini Mental State Examination; PD, Parkinson's disease; PSP, progressive supranuclear palsy.